TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A registered dietitian says research suggests zinc lozenges started soon after cold symptoms begin may shorten illness, but the evidence is not conclusive. Studies have used doses above some public-health limits, and zinc can cause side effects and interact with medicines.
A registered dietitian says zinc lozenges may shorten a common cold by about two days when started early, but the evidence remains low-certainty and inconclusive. The finding matters because doses used in some studies exceed established adult intake limits, so the possible benefit does not establish that high-dose zinc is safe for self-treatment.
Dietitian Johannah Katz told Fit&Well that a 2024 Cochrane review found zinc may reduce cold duration by around two days. The review’s evidence was rated low certainty, Katz said, because trials varied substantially in their dose, formulation and design. It did not find convincing evidence that zinc meaningfully reduces overall symptom severity.
Katz said the research points more toward lozenges than swallowed tablets, with potential benefit strongest when treatment begins soon after symptoms appear, ideally within 24 hours. Zinc acetate and zinc gluconate lozenges have both shown benefit, she said; a meta-analysis did not find a significant difference between them. She advised looking at the amount of elemental zinc listed, rather than the total weight of the zinc compound.
Some trials reporting benefits used roughly 75 to 90 milligrams of elemental zinc daily, often for less than two weeks. Katz said there is no evidence that taking more than about 100 mg daily works better. These study amounts are above the US adult tolerable upper intake level of 40 mg a day, which includes zinc from food and supplements; NHS guidance advises adults not to take more than 25 mg of zinc supplements daily unless a doctor advises it.
Potential Benefit Comes With Dose Risks
The research offers a possible short-term option for people already experiencing cold symptoms, but it does not support treating zinc as a proven cure or as a routine preventive supplement. Katz said the Cochrane review found preventive zinc may have little or no effect on whether someone develops a cold; the possible benefit appears more relevant to short-term use after symptoms start.
The gap between doses studied and public-health limits makes the findings harder to apply without advice. Katz described nausea, stomach upset and a metallic or unpleasant taste as common side effects. She also warned that long-term high-dose zinc can interfere with copper absorption and may impair immune function. People taking medicines should check with a pharmacist because zinc can interact with tetracycline and quinolone antibiotics and penicillamine.
For readers, the central point is not that zinc reliably ends a cold sooner, but that some research suggests a modest reduction in duration under particular conditions. The formulation, timing and dose may matter, while the evidence does not settle the best approach for an individual or establish that higher doses are appropriate.
As an affiliate, we earn on qualifying purchases.
What the Cold Studies Examined
Zinc is an essential mineral involved in normal immune function. The Fit&Well report says researchers have proposed that zinc could affect how cold viruses spread or reproduce, and that lozenges may release zinc locally in the mouth and throat. The mechanism remains a hypothesis: the report says scientists have not confirmed how zinc might produce any effect.
The supplied report also refers to a meta-analysis of seven trials involving lozenges with more than 75 mg of zinc. It says those trials found colds were, on average, 33% shorter compared with placebo. That result comes from a limited set of trials and should be read alongside the Cochrane review’s assessment of low certainty and its finding that overall symptom severity was not convincingly reduced.
These findings concern zinc supplementation during a cold, not a general claim that zinc prevents infection. The report distinguishes lozenges from nasal products: Katz advised avoiding intranasal zinc sprays or gels because they have been linked to potentially permanent loss of smell.
As an affiliate, we earn on qualifying purchases.
Limits of the Zinc Evidence
The source report does not establish that zinc will shorten a cold for a particular person. The Cochrane review’s evidence was rated low certainty, and study results may not apply uniformly because researchers used different doses, products and trial designs. A possible average reduction in duration is not a guarantee, and the review did not find convincing evidence of a meaningful reduction in overall symptom severity.
The report does not provide enough detail to determine which specific dose or schedule offers the best balance of benefit and risk. It also does not establish the proposed antiviral mechanism. The cited 33% average reduction comes from a seven-trial meta-analysis, while the broader review characterizes the evidence as uncertain; the supplied material does not give enough information to reconcile differences in study selection or methods.
People’s health conditions and medications can affect whether supplementation is suitable. The report does not offer individual medical guidance. Anyone considering high-dose zinc, especially someone taking prescription medicines, should check with a pharmacist or healthcare professional rather than treating the study doses as a general recommendation.
As an affiliate, we earn on qualifying purchases.
How Readers Should Interpret the Findings
The next step for readers is to weigh the potential for a modestly shorter cold against uncertain results, side effects and the dose limits cited in the report. Katz advises checking with a pharmacist or healthcare professional before taking doses above usual limits, and specifically cautions people on interacting medicines. The evidence presented does not support routine preventive zinc use or nasal zinc products.
The supplied report does not announce a new trial or a change in official guidance. A clearer answer would depend on further research using consistent lozenge formulations, doses and trial designs, with safety and symptom outcomes reported clearly. Until then, zinc should be described as a possible early intervention, not a confirmed way to end a cold.
As an affiliate, we earn on qualifying purchases.
Key Questions
Can zinc make a cold go away faster?
Some research suggests zinc lozenges may shorten a cold, with Katz citing a Cochrane review estimate of around two days. The evidence was rated low certainty, so this is a possible average effect, not a guarantee.
When would zinc need to be started?
Katz said the strongest evidence supports starting very early, ideally within 24 hours of the first symptoms. The report does not establish that later use has the same potential benefit.
Are zinc lozenges better than tablets?
Katz said the evidence is better for lozenges than for swallowed tablets. Both zinc acetate and zinc gluconate lozenges have shown benefit, with no significant difference between them in the meta-analysis she cited.
Are the doses studied within usual safety limits?
Not necessarily. Trials reporting benefits commonly used about 75 to 90 mg of elemental zinc daily. The report cites a US adult upper intake level of 40 mg a day from food and supplements, while NHS guidance says not to take more than 25 mg of zinc supplements daily unless advised by a doctor. Check with a pharmacist or healthcare professional before taking high doses.
Should I use zinc nasal spray for a cold?
Katz advises avoiding intranasal zinc sprays or gels because they have been linked to potentially permanent loss of smell. The report discusses lozenges separately from nasal products.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
